OKT With Gaze and Postural Stabilization on Vertigo, MS and QOL in VBH
4. mai 2026 oppdatert av: Riphah International University
Effects of Optokinetic Training With Gaze and Postural Stabilization on Vertigo, Motion Sickness and Quality of Life in Vestibular Hypofunction
The objective of this study will evaluate the effects of optokinetic training combined with postural stabilization and gaze stability exercises on motion sickness, balance, gaze stability, and quality of life in individuals with vestibular hypofunction.
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
A randomized clinical trial will be conducted with 32 participants assigned to two groups: Group A (breathing and aerobic exercises) and Group B (optokinetic training combined with postural stabilization and gaze stability exercises).
Data will be collected using the Motion Sickness Susceptibility Questionnaire (MSSQ), Berg Balance Scale (BBS), Dynamic Visual Acuity Test for Gaze Stability, and Head Impulse Test.
Statistical analysis will be performed by SPSS.
Studietype
Intervensjonell
Registrering (Antatt)
32
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Muneeb Khan, PhD
- Telefonnummer: 923367993611
- E-post: muneeb.khan@riphah.edu.pk
Studiesteder
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54500
- Ittefaq Hospital Lahore
-
Ta kontakt med:
- Javeria Ghazal, MSNMPT
- Telefonnummer: +923335154664
- E-post: javeria.ghazal@riphah.edu.pk
-
Hovedetterforsker:
- Asad Shahzad Mir, MsNMPT
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
• Male and female patients age 20 and 40 years
- Passengers who have motion sickness during travelling
- Patients of vestibular migraine who experience motion sickness
- Participants experiencing vertigo, dizziness or imbalance related to vestibular hypofunction over the past three months
Exclusion Criteria:
• Patients who have seasickness and simulator sickness excluded.
- Patients having vestibular disease and chronic neurological disease.
- Participants who have completed formal vestibular rehabilitation in last 6 months excluded
- Patients with severe visual impairments and orthopedic conditions excluded.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Group A Habituation exercises
Group A performed a regime of Habituation exercises five times per week to improve overall wellness and reduce baseline symptoms of motion sickness
|
Habituation exercises five times per week to improve overall wellness and reduce baseline symptoms of motion sickness (38).
Each session, lasting approximately 20-25 minutes, involved exercises conducted for 20 minutes per day, five times a week.
Each session, lasting approximately 30-45 minutes, included low-intensity breathing exercises aimed at promoting relaxation and moderate-intensity aerobic activities, such as walking or cycling, at 50-60% of the participant's maximum heart rate.
|
|
Eksperimentell: Group B Optokinetic training protocol
Group B underwent a structured optokinetic training protocol combined with postural stabilization and gaze stability exercises, targeting both gaze and postural control systems.
|
10-minute warm-up, followed by 20-25 minutes of moderate-intensity optokinetic exercises (viewing controlled moving visual patterns), postural exercises involving controlled head and body movements to engage the vestibular system, and gaze stability exercises, which require focusing on a stationary target during head movements to improve the vestibulo-ocular reflex.
The session concluded with a 10-15-minute cool-down to aid relaxation.
These sessions continued for 12 weeks
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Motion sickness susceptibility questionnaire
Tidsramme: 8th week
|
The Motion Sickness Susceptibility Questionnaire (MSSQ) is a widely used tool that assesses an individual's predisposition to motion sickness in various environments, such as vehicles, amusement rides, and virtual reality.
|
8th week
|
|
Berg balance scale
Tidsramme: 8th week
|
The Berg Balance Scale (BBS) is a reliable clinical tool used to assess balance in individuals, particularly older adults and those with balance impairments.
It includes 14 tasks each scored from 0 (cannot perform) to 4 (performs independently).
The BBS has a maximum score of 56, and most of the patients show a low fall risk of 41 to 56 scores, medium risk of 21 to 40 scores, and a high risk of 0 to 20 scores.
|
8th week
|
|
Dynamic visual acuity test for gaze stability
Tidsramme: 8th week
|
The Dynamic Visual Acuity (DVA) Test is a widely used clinical test to assess gaze stability, particularly in individuals with vestibular dysfunction.
It evaluates a person's ability to maintain clear vision during head movements, which requires stable gaze control.
The test involves reading porotype letters or symbols displayed on a screen, first in a stationary position and then while moving the head horizontally and vertically at a standardized speed (usually around 2 Hz)
|
8th week
|
|
Head impulse test
Tidsramme: 8th week
|
The Head Impulse Test (HIT) is a diagnostic tool used to evaluate the function of the vestibulo-ocular reflex (VOR), essential for maintaining gaze stability during rapid head movements.
In this test, a clinician rapidly and unpredictably turns the patient's head to the left or right while the patient focuses on a stationary target, typically the clinician's nose.
For a healthy VOR, the eyes should remain fixed on the target despite the head movement
|
8th week
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Javeria Ghazal, MSNMPT, Riphah International University
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
15. mai 2026
Primær fullføring (Antatt)
15. august 2026
Studiet fullført (Antatt)
14. september 2026
Datoer for studieregistrering
Først innsendt
22. februar 2026
Først innsendt som oppfylte QC-kriteriene
4. mai 2026
Først lagt ut (Faktiske)
8. mai 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
8. mai 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
4. mai 2026
Sist bekreftet
1. mai 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- REC/RCR & AHS/24/02100
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .